PineBridge Investments’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,727
Closed -$79K 1143
2019
Q3
$79K Sell
3,727
-27,033
-88% -$741K ﹤0.01% 972
2019
Q2
$978K Buy
30,760
+20,261
+193% +$635K 0.02% 695
2019
Q1
$347K Buy
10,499
+150
+1% +$4.67K 0.01% 771
2018
Q4
$333K Buy
10,349
+2,430
+31% +$91.7K 0.01% 767
2018
Q3
$340K Buy
7,919
+2,302
+41% +$109K 0.01% 813
2018
Q2
$259K Buy
+5,617
New +$249K 0.01% 830
2017
Q4
Sell
-2,391
Closed -$88K 1127
2017
Q3
$88K Sell
2,391
-79
-3% -$2.97K ﹤0.01% 968
2017
Q2
$92K Buy
2,470
+53
+2% +$1.73K ﹤0.01% 935
2017
Q1
$68K Buy
2,417
+63
+3% +$1.78K ﹤0.01% 989
2016
Q4
$69K Hold
2,354
﹤0.01% 1036
2016
Q3
$64K Buy
2,354
+6
+0.3% +$136 ﹤0.01% 916
2016
Q2
$44K Buy
2,348
+220
+10% +$4.59K ﹤0.01% 977
2016
Q1
$58K Sell
2,128
-302
-12% -$8.66K ﹤0.01% 885
2015
Q4
$73K Buy
+2,430
New +$78K ﹤0.01% 859

Other funds holding PAHC

PineBridge Investments's PAHC Position: Q4 2019 in Review

PineBridge Investments sold out of Phibro Animal Health (PAHC) in Q4 2019, closing a stake of 3,727 shares — an estimated $79K sold.

PineBridge Investments first reported a position in PAHC in Q4 2015 and held it in 14 quarters. The position peaked at $978K in Q2 2019. 155 funds tracked by Wall St. Rank hold PAHC as of Q4 2019.

  • PineBridge Investments reported no remaining Phibro Animal Health position as of Q4 2019 after selling out during the quarter.
  • PineBridge Investments sold 3,727 Phibro Animal Health shares in Q4 2019, an estimated $79K.
  • PineBridge Investments first reported a position in Phibro Animal Health in Q4 2015 and held it in 14 quarters.
  • PineBridge Investments's Phibro Animal Health position peaked at $978K in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2019.

Based on PineBridge Investments's 13F filing for Q4 2019, filed 13 Feb 2020.